Study identifies potential markers of lung cancer

By examining both blood samples and tumor tissues from patients with non-small-cell lung cancer (NSCLC), investigators at Massachusetts General Hospital (MGH) have identified markers that can distinguish between major subtypes of lung cancer and can accurately identify lung cancer stage. Their proof-of-concept test accurately predicted whether the blood samples they examined came from patients with shorter or longer survival following lung cancer surgery, including patients with early-stage disease.

source https://www.lifetechnology.com/blogs/life-technology-news-blog/study-identifies-potential-markers-of-lung-cancer